Rationale for targeting complement in COVID-19 (2020)
Attributed to:
A flow cytometry facility for ocular regenerative medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 12
Parent Publication: EMBO MOLECULAR MEDICINE
Issue: 8
ISSN: 1757-4676